O⁶-benzylguanine and BCNU in multiple myeloma: a phase II trial

By Batts Eric   Maisel Christopher   Kane Donna   Liu Lili   Fu Pingfu   O’Brien Timothy   Remick Scot   Bahlis Nizar   Gerson Stanton  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 415-421

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma

By Phuphanich Surasak   Supko Jeffrey   Carson Kathryn   Grossman Stuart   Burt Nabors L.   Mikkelsen Tom   Lesser Glenn   Rosenfeld Steve   Desideri Serena   Olson Jeffrey  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 95-103

Springer Publishing Company

Access to resources Recommend Favorite

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

By Jaeckle Kurt   Ballman Karla   Giannini Caterina   Schomberg Paula   Ames Matthew   Reid Joel   McGovern Renee   Safgren Stephanie   Galanis Evanthia   Uhm Joon   Brown Paul   Hammack Julie   Arusell Robert   Nikcevich Daniel   Morton Roscoe   Wender Donald   Buckner Jan  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 73-80

Springer Publishing Company

Access to resources Recommend Favorite

Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study

By Fabi Alessandra   Metro Giulio   Vidiri Antonello   Lanzetta Gaetano   Carosi Mariantonia   Telera Stefano   Maschio Marta   Russillo Michelangelo   Sperduti Isabella   Carapella Carmine   Cognetti Francesco   Pace Andrea  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 209-215

Springer Publishing Company

Access to resources Recommend Favorite

Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor – a pharmacokinetic study

By Hamstra1 Daniel   Moffat Bradford   Hall Daniel   Young John   Desmond Timothy   Carter Julie   Pietronigro Dennis   Frey Kirk   Rehemtulla1 Alnawaz   Ross Brian  

Journal of Neuro-Oncology, Vol. 73, Iss. 3, 2005-07 ,pp. : 225-238

Springer Publishing Company

Access to resources Recommend Favorite